Life ScienceCompany
Mallinckrodt M&A Summary
Mallinckrodt has acquired 15 companies, including 1 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 7 assets.
Mallinckrodt’s largest acquisition to date was in 2014, when it acquired Questcor Pharmaceuticals for $5.8B. It’s largest disclosed sale occurred in 2024, when it sold Therakos to CVC Capital Partners for $925M. Mallinckrodt has acquired in 8 different US states, and 2 countries. The Company’s most targeted sectors include life science (75%) and medical products (25%).
Mallinckrodt Business Overview
Where is Mallinckrodt headquartered?
Mallinckrodt is headquartered in Dublin, United Kingdom.
What is Mallinckrodt’s revenue?
Mallinckrodt disclosed revenue of 2,208M USD for 2021 and 2,213M USD for 2020.
How many employees does Mallinckrodt have?
Mallinckrodt has 2,673 employees.
What sector is Mallinckrodt in?
Mallinckrodt is a life science company.
When was Mallinckrodt founded?
Mallinckrodt was founded in 1867.
M&A Summary
-
M&A Total Activity19
- M&A Buy Activity12
- M&A Sell Activity7
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 14
- M&A Advisors 6
Unlimited Searches
